GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Equity-to-Asset

3SBio, (FRA:YFK) Equity-to-Asset : 0.59 (As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. 3SBio,'s Total Stockholders Equity for the quarter that ended in Dec. 2016 was €893.6 Mil. 3SBio,'s Total Assets for the quarter that ended in Dec. 2016 was €1,512.3 Mil. Therefore, 3SBio,'s Equity to Asset Ratio for the quarter that ended in Dec. 2016 was 0.59.

The historical rank and industry rank for 3SBio,'s Equity-to-Asset or its related term are showing as below:

FRA:YFK' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17   Med: 0.89   Max: 0.97
Current: 0.59

During the past 13 years, the highest Equity to Asset Ratio of 3SBio, was 0.97. The lowest was 0.17. And the median was 0.89.

FRA:YFK's Equity-to-Asset is not ranked
in the Biotechnology industry.
Industry Median: 0.67 vs FRA:YFK: 0.59

3SBio, Equity-to-Asset Historical Data

The historical data trend for 3SBio,'s Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Equity-to-Asset Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.93 0.40 0.85 0.59

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.82 0.85 0.54 0.59

Competitive Comparison of 3SBio,'s Equity-to-Asset

For the Biotechnology subindustry, 3SBio,'s Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Equity-to-Asset falls into.



3SBio, Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

3SBio,'s Equity to Asset Ratio for the fiscal year that ended in Dec. 2016 is calculated as

Equity to Asset (A: Dec. 2016 )=Total Stockholders Equity/Total Assets
=893.57/1512.296
=0.59

3SBio,'s Equity to Asset Ratio for the quarter that ended in Dec. 2016 is calculated as

Equity to Asset (Q: Dec. 2016 )=Total Stockholders Equity/Total Assets
=893.57/1512.296
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio,  (FRA:YFK) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


3SBio, Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines